EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Heart Transplant Rejection: From Histological Diagnosis to Precision Medicine

Andrea Marzullo iD, Cecilia Salzillo iD

Reviews in Cardiovascular Medicine · 14.10.2026 · 27 (10)

DOI: 10.31083/rcm50555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 14.10.2026. Verfasst von Andrea Marzullo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area, Pathology Unit, University of Bari "Aldo Moro", 70124 Bari, Italy. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart transplantation remains the treatment of choice for patients with end-stage heart failure who are unresponsive to medical therapy or ventricular assist devices. Despite significant advances in surgical techniques and immunosuppressive protocols, heart transplant rejection (HTR) remains a major cause of morbidity and mortality among recipients. This narrative review summarizes current knowledge on HTR, with particular emphasis on immunopathogenic mechanisms, diagnostic approaches, histological classification, and therapeutic strategies, including the most recent non-invasive monitoring techniques. A narrative review of recent literature was conducted, including key publications and the updated International Society for Heart and Lung Transplantation (ISHLT) guidelines on rejection mechanisms, histological grading systems, and therapeutic strategies. HTR occurs via hyperacute, acute cellular, antibody-mediated, and chronic mechanisms, each characterized by complex immunological interactions between donor and recipient. Endomyocardial biopsy (EMB) remains the diagnostic gold standard, while innovations such as gene expression profiling, donor-derived cell-free DNA (dd-cfDNA), and donor-specific antibody (DSA) testing are redefining rejection monitoring. Modern immunosuppressive therapies, particularly tacrolimus-based regimens and B-cell-targeted agents, have reduced the incidence of rejection and improved graft survival. Ongoing refinement of diagnostic techniques and personalized immunosuppressive strategies is essential to enhance post-transplant outcomes. A multidisciplinary approach remains crucial for optimal management of HTR.

Schlagwörter

Stichwörter der Autor:innen

biomarkersendomyocardial biopsyheart transplant rejectionheart transplantationimmunosuppression

Autor:innen und Institutionen

  • Department of Precision and Regenerative Medicine and Ionian Area, Pathology Unit, University of Bari "Aldo Moro", 70124 Bari, Italy.

ORCID-Profile: Andrea Marzullo, Cecilia Salzillo

Zitieren

APA

Marzullo, A., & Salzillo, C. (2026). Heart Transplant Rejection: From Histological Diagnosis to Precision Medicine. Reviews in Cardiovascular Medicine, 27(10). https://doi.org/10.31083/rcm50555

Vancouver

Marzullo A, Salzillo C. Heart Transplant Rejection: From Histological Diagnosis to Precision Medicine. Reviews in Cardiovascular Medicine. 2026;27(10). doi:10.31083/rcm50555

BibTeX
@article{Marzullo2026,
  author = {Marzullo, Andrea and Salzillo, Cecilia},
  title = {Heart Transplant Rejection: From Histological Diagnosis to Precision Medicine},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {10},
  doi = {10.31083/rcm50555}
}
Kostenlos starten →